ePulmonology Review Volume 1 is organized by Johns Hopkins Medicine (JHM) and will be held from Feb 28, 2018 - Jul 24, 2020.
The target audience for this medical event is pulmonologists, primary care physicians, respiratory therapists, nurses, nurse practitioners, physician assistants, and others treating patients with pulmonary conditions.
Credit Designation Statements:
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 3 contact hours for the 3 newsletters in this program.
Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 1.5 contact hours for the 3 podcasts in this program.
Time : 60 minutes per newsletter, 30 minutes per podcast.
Conference Description :
The ePulmonology Review series will consist of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with HIV. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of HIV specialists. The activities are delivered as 6 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 6 podcasts in order to earn CME credit.
Conference Objectives are :
• Describe the importance of accurate classification in diagnosis and disease management of pulmonary hypertension.
• Identify patient-provider communication techniques to improve adherence to therapeutic agents and patient outcomes.
• Explain how the GOLD guidelines assist in diagnosing and managing treatments in patients with COPD.
• Compare current and emerging therapies in COPD to identify the potential for individualizing therapies based on patients’ needs.
Additional details will be posted as soon as they are available.